Dr. Liebeskind is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UCLA Medical Center
710 Westwood Plaza, C119 RNRC
Los Angeles, CA 90095Phone+1 310-794-6379Fax+1 310-794-6379
Summary
- Dr. David Liebeskind is a neurologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica. He received his medical degree from NYU School of Medicine and has been in practice 22 years. He also speaks multiple languages, including Spanish. He specializes in neuroimaging and vascular neurology and is experienced in general neurology, stroke, cerebrovascular disease, carotid disease, and neuroimaging.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1996 - 1999
- Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1995 - 1996
- New York University School of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 1997 - 2025
- PA State Medical License 1999 - 2004
- NY State Medical License 1999 - 2002
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Vascular Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2021
Clinical Trials
- Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) Start of enrollment: 2008 Jul 01
- A Study to Evaluate the Effects of the Neuroflo Device in People Who Have Had a Stroke Start of enrollment: 2008 Mar 01
- Safety Study of External Counterpulsation as a Treatment for Acute Ischemic Stroke Start of enrollment: 2009 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 212 citationsSafety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.David C. Hess, Lawrence R. Wechsler, Wayne M. Clark, Sean I Savitz, Gary A. Ford
The Lancet. Neurology. 2017-05-01 - 28 citationsDecline in mild stroke presentations and intravenous thrombolysis during the COVID-19 pandemic: The Society of Vascular and Interventional Neurology Multicenter Collab...Santiago Ortega-Gutierrez, Mudassir Farooqui, Alicia Zha, Alexandra L Czap, Jacob Sebaugh
Clinical Neurology and Neurosurgery. 2021-02-01 - 18 citationsDelays in thrombolysis during COVID-19 are associated with worse neurological outcomes: the Society of Vascular and Interventional Neurology Multicenter Collaboration.Dinesh V Jillella, Fadi Nahab, Thanh N. Nguyen, Mohamad Abdalkader, David S Liebeskind
Journal of Neurology. 2021-07-31
Journal Articles
- Thrombectomy 6 to 24 Hours After Stroke with a Mismatch Between Deficit and InfarctElad I. Levy, Qaisar A. Shah, Jawad F. Kirmani, Parita Bhuva, Cathy A. Sila, Michael G. Abraham, Amin Aghaebrahim, Wade S. Smith, Raul G. Nogueira, Brijesh P. Mehta, P..., The New England Journal of Medicine
Other
- Spontaneous cerebral and cervical artery dissection: Treatment and prognosisLiebeskind DS, Saver J
http://www.uptodate.com/contents/spontaneous-cerebral-and-cervical-artery-dissection-treatment-and-p
UpToDate, Wolters Kluwer Health - 2012-09-19 - Spontaneous cerebral and cervical artery dissection: Clinical features and diagnosisLiebeskind DS, Saver J
http://www.uptodate.com/contents/spontaneous-cerebral-and-cervical-artery-dissection-clinical-featur
UpToDate, Wolters Kluwer Health - 2013-01-02
Authored Content
- Thrombectomy 6 to 24 Hours After Stroke with a Mismatch Between Deficit and InfarctNovember 2017
- Thrombectomy 6 to 24 Hours After Stroke with a Mismatch Between Deficit and InfarctNovember 2017
- Thrombectomy 6 to 24 Hours After Stroke with a Mismatch Between Deficit and InfarctNovember 2017
Press Mentions
- Medication That Protects Brain Tissue Linked to Improved Stroke SurvivalFebruary 8th, 2023
- Smartphone App May Help Identify Stroke Symptoms as They OccurFebruary 2nd, 2023
- Covid-19 Two Years on: Persistent Symptoms of Clinical Trial Disruption Trouble Certain Therapy AreasMarch 31st, 2022
- Join now to see all
Grant Support
- Modeling Of Collateral Perfusion In The Ischemic BrainNational Institute Of Neurological Disorders And Stroke2011
- Therapeutic Aqueous Oxygen In Stroke (TAO)National Institute Of Neurological Disorders And Stroke2008–2011
- Neuroimaging CoreNational Institute Of Neurological Disorders And Stroke2008–2011
- Collateral Circulation In Acute Ischemic StrokeNational Institute Of Neurological Disorders And Stroke2006–2010
Professional Memberships
- Society of Vascular and Interventional Neurology (SVIN)President
- American Society of Neuroimaging (ASN)Past-President
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: